Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis
Authors:
- Franco AntoniazziFAFranco Antoniazzi
- Francesco BertoldoFBFrancesco Bertoldo
- Monica MottesMMMonica Mottes
- Maurizia ValliMVMaurizia Valli
- Stefania SirpresiSSStefania Sirpresi
- Giorgio ZamboniGZGiorgio Zamboni
- Roberta ValentiniRVRoberta Valentini
- Luciano TatòLTLuciano Tatò
- 1 September 1996
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 129 (3) , 432-439
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Bone mineral content and density in healthy subjects and in osteogenesis imperfecta.Archives of Disease in Childhood, 1994
- Serum concentrations of procollagen I C‐terminal propeptide, osteocalcin and insulin‐like growth factor‐I in patients with non‐lethal osteogenesis irnperfectaActa Paediatrica, 1993
- Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta.Journal of Clinical Investigation, 1993
- Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiencyThe Journal of Pediatrics, 1993
- Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiencyThe Journal of Pediatrics, 1991
- Growth Hormone and BoneHormone Research, 1991
- Osteocalcin levels in osteogenesis imperfectaThe Journal of Pediatrics, 1987
- Plasma osteocalcin levels in patients with osteogenesis imperfectaThe Journal of Pediatrics, 1986
- Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.Journal of Clinical Investigation, 1985
- Nonoperative Treatment of Osteogenesis ImperfectaClinical Orthopaedics and Related Research, 1981